Admitted local publications that cite Dual inhibition of p38α MAPK and Casein kinase δ/ε as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer.
No admitted local citation edges point to this work yet.
Cited by — Dual inhibition of p38α MAPK and Casein kinase δ/ε as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer | ResearchHub - ResearchHub
